Arcus Investment
VC Fund
London, United Kingdom
Arcus Investment is an asset management firm that provides an investment platform for value opportunities in Japan to investors.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Arcus Investment invests in
Stages Arcus Investment invests in
Countries Arcus Investment invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Investment Focus
Industry
- Health Care 2 (100%)
- Beauty 1 (50%)
- Medical 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Seed 1 (50%)
- Series D 1 (50%)
Country
- Japan 1 (50%)
- Austria 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Mark Pearson
Co-Founder and Head of Portfolio Management (Hong Kong)
|
Co-Founder and Head of Portfolio Management (Hong Kong) | Total investments: 0 | Find email | |
|
Peter Tasker
Co-Founder and Strategist (Tokyo)
|
Co-Founder and Strategist (Tokyo) | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Innovacell
|
Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts. | Series D / Aug 21, 2025 | |
Heartseed
|
Heartseed is a biotechnology research firm that specializes in the development of purified ventricular cardiomyocytes derived from induced pluripotent stem cells for the treatment of heart failure. The company employs an innovative methodology that involves the creation of cardiomyocyte spheroids, small clusters of heart cells, using stem cells.These spheroids are then surgically implanted into the heart to improve its performance. | $14.3M / Seed / May 25, 2023 |
Co-Investors
Alfresa Holdings
1 deal together
Aska Pharmaceutical
1 deal together
Happiness Capital
1 deal together
Keio Innovation Initiative
1 deal together
KOEI TECMO CAPITAL
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Arcus Investment invest in?
Arcus Investment invests primarily in Health Care, Beauty and Medical startups, most often at Seed and Series D stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Arcus Investment?
Public channels for Arcus Investment include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Arcus Investment?
The team at Arcus Investment includes Mark Pearson (Co-Founder and Head of Portfolio Management (Hong Kong)) and Peter Tasker (Co-Founder and Strategist (Tokyo)). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
